Evolent Health, Inc. - EVH
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 26, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Eventide Asset Management, LLC | 0.0% | 1,713 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Finny Kuruvilla, M.D. Ph. D. | 0.0% | 1,713 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Robin C. John | 0.0% | 1,713 | View |
| Feb 11, 2026 | SCHEDULE 13G/A | Morgan Stanley | 8.1% | 9,097,808 | View |
| Feb 11, 2026 | SCHEDULE 13G/A | Morgan Stanley Capital Services LLC | 6.6% | 7,380,233 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | FMR LLC | 0.7% | 750,887 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 0.7% | 750,887 | View |
| Jan 30, 2026 | SCHEDULE 13G/A | The Vanguard Group | 7.98% | 8,914,065 | View |
| Nov 14, 2025 | SCHEDULE 13G | Rubicon Fund II LP | 4.51% | 5,032,469 | View |
| Nov 14, 2025 | SCHEDULE 13G | Rubicon Fund II PF LP | 0.7% | 783,654 | View |
| Nov 14, 2025 | SCHEDULE 13G | Rubicon OP GP II LP | 5.21% | 5,816,123 | View |
| Nov 14, 2025 | SCHEDULE 13G | Rubicon OP GP II LLC | 5.21% | 5,816,123 | View |
| Nov 14, 2025 | SCHEDULE 13G | Rubicon Founders LLC | 5.21% | 5,816,123 | View |
| Nov 14, 2025 | SCHEDULE 13G | Boehler Adam | 5.21% | 5,816,123 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Eventide Asset Management, LLC | 5.4% | 6,292,511 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Finny Kuruvilla, M.D. Ph. D. | 5.4% | 6,292,511 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Robin C. John | 5.4% | 6,292,511 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Durable Capital Partners LP | 0.0% | 0 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | FMR LLC | 8.0% | 9,416,813 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | Abigail P. Johnson | 8.0% | 9,416,813 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.